Phocas Financial Corp. Decreases Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Phocas Financial Corp. decreased its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 80.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 14,330 shares of the company’s stock after selling 57,895 shares during the period. Phocas Financial Corp.’s holdings in Acadia Healthcare were worth $568,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Raymond James & Associates lifted its position in shares of Acadia Healthcare by 24.8% during the 3rd quarter. Raymond James & Associates now owns 124,202 shares of the company’s stock valued at $7,876,000 after buying an additional 24,709 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare in the 3rd quarter valued at about $86,000. State of Alaska Department of Revenue lifted its holdings in Acadia Healthcare by 7.3% during the third quarter. State of Alaska Department of Revenue now owns 10,735 shares of the company’s stock valued at $680,000 after purchasing an additional 730 shares during the last quarter. Congress Asset Management Co. boosted its position in Acadia Healthcare by 16.8% during the third quarter. Congress Asset Management Co. now owns 118,941 shares of the company’s stock worth $7,542,000 after purchasing an additional 17,127 shares during the period. Finally, Harbor Capital Advisors Inc. increased its stake in shares of Acadia Healthcare by 90.7% in the third quarter. Harbor Capital Advisors Inc. now owns 22,582 shares of the company’s stock worth $1,432,000 after purchasing an additional 10,740 shares in the last quarter.

Acadia Healthcare Stock Up 4.1 %

Shares of NASDAQ ACHC opened at $42.35 on Wednesday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The business has a 50-day moving average of $42.18 and a 200-day moving average of $52.38. The firm has a market capitalization of $3.93 billion, a price-to-earnings ratio of 13.89, a PEG ratio of 1.46 and a beta of 1.30. Acadia Healthcare Company, Inc. has a 12 month low of $36.50 and a 12 month high of $87.77.

Wall Street Analyst Weigh In

ACHC has been the subject of several analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a report on Friday, January 10th. TD Cowen cut their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Finally, KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.